Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.

McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N.

Blood. 2010 Dec 2;116(23):5037-44. doi: 10.1182/blood-2010-06-293126. Epub 2010 Aug 24.

2.

Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells.

McEachron TA, Church FC, Mackman N.

Blood Coagul Fibrinolysis. 2011 Oct;22(7):576-82. doi: 10.1097/MBC.0b013e3283497647.

PMID:
21799402
3.

Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.

Grandaliano G, Pontrelli P, Cerullo G, Monno R, Ranieri E, Ursi M, Loverre A, Gesualdo L, Schena FP.

J Am Soc Nephrol. 2003 Aug;14(8):2072-83.

4.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
5.

Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis.

Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, Gesualdo L, Schena FP.

Transplantation. 2001 Oct 27;72(8):1437-43.

PMID:
11685117
6.

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.

Idell S.

Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. Review.

PMID:
12682443
7.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
8.

Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.

Int J Oncol. 2006 Apr;28(4):807-14.

PMID:
16525628
9.

Protein C and its inhibitor in malignancy.

Suzuki K, Hayashi T.

Semin Thromb Hemost. 2007 Oct;33(7):667-72. Review.

PMID:
18000793
10.

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.

Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.

J Cancer Res Clin Oncol. 2000 Nov;126(11):641-6.

PMID:
11079728
11.
12.

Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.

Guiducci S, Del Rosso A, Cinelli M, Margheri F, D'Alessio S, Fibbi G, Matucci Cerinic M, Del Rosso M.

Clin Exp Rheumatol. 2005 May-Jun;23(3):364-72.

PMID:
15971425
13.

Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.

Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70.

PMID:
15790903
14.
15.

Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system.

Fibbi G, Pucci M, D'Alessio S, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M.

Growth Factors. 2001;19(2):87-100.

PMID:
11769974
16.

Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.

Tanaka A, Suzuki Y, Sugihara K, Kanayama N, Urano T.

Life Sci. 2009 Jul 31;85(5-6):220-5. doi: 10.1016/j.lfs.2009.05.014. Epub 2009 Jun 3.

PMID:
19500599
17.
18.
19.

Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.

Wojta J, Nakamura T, Fabry A, Hufnagl P, Beckmann R, McGrath K, Binder BR.

Blood. 1994 Jul 1;84(1):151-7.

20.

Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.

Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ.

Cancer Res. 2000 Oct 15;60(20):5839-47.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk